Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E M Kelly

Showing results (101-110 of 116) with videos related to

Pageof 12
Sort By:
Journal of Neurophysiology|July 2, 2002
T-Type calcium channel alpha1G and alpha1H subunits in human retinoblastoma cells and their loss after differentiationKazuyuki Hirooka, Gabriel E Bertolesi, Melanie E M Kelly, et al.
Clinical Hemorheology and Microcirculation|April 10, 2018
DIBI, a polymeric hydroxypyridinone iron chelator, reduces ocular inflammation in local and systemic endotoxin-induced uveitisN Arora, A Caldwell, K Wafa, et al.
Neuropharmacology|August 20, 2018
Revisiting cannabinoid receptor 2 expression and function in murine retinaJoanna Borowska-Fielding, Natalia Murataeva, Ben Smith, et al.
Neuropharmacology|April 4, 2019
Positive allosteric modulation of the type 1 cannabinoid receptor reduces the signs and symptoms of Huntington's disease in the R6/2 mouse modelRobert B Laprairie, Amina M Bagher, Jillian L Rourke, et al.
ACS Chemical Neuroscience|January 20, 2017
Enantiospecific Allosteric Modulation of Cannabinoid 1 ReceptorRobert B Laprairie, Pushkar M Kulkarni, Jeffrey R Deschamps, et al.
ACS Chemical Neuroscience|April 6, 2016
Mapping Cannabinoid 1 Receptor Allosteric Site(s): Critical Molecular Determinant and Signaling Profile of GAT100, a Novel, Potent, and Irreversibly Binding ProbeRobert B Laprairie, Abhijit R Kulkarni, Pushkar M Kulkarni, et al.
Molecules (Basel, Switzerland)|September 22, 2019
Selective Cannabinoid 2 Receptor Agonists as Potential Therapeutic Drugs for the Treatment of Endotoxin-Induced UveitisRichard Frederick Porter, Anna-Maria Szczesniak, James Thomas Toguri, et al.
Toxicology Letters|January 26, 2021
Dose-dependent emergence of acute and recurrent corneal lesions in sulfur mustard-exposed rabbit eyesPatrick M McNutt, Kyle E M Kelly, Amber C Altvater, et al.
Journal of Medicinal Chemistry|April 7, 2021
Discovery of a Biased Allosteric Modulator for Cannabinoid 1 Receptor: Preclinical Anti-Glaucoma EfficacySumanta Garai, Luciana M Leo, Anna-Maria Szczesniak, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|October 6, 2022
Clinical, Virologic, and Immunologic Evaluation of Symptomatic Coronavirus Disease 2019 Rebound Following Nirmatrelvir/Ritonavir TreatmentBrian P Epling, Joseph M Rocco, Kristin L Boswell, et al.
Pageof 12

Showing results (101-110 of 116) with videos related to

Sort By:
Pageof 12
Journal of Neurophysiology|July 2, 2002
T-Type calcium channel alpha1G and alpha1H subunits in human retinoblastoma cells and their loss after differentiationKazuyuki Hirooka, Gabriel E Bertolesi, Melanie E M Kelly, et al.
Clinical Hemorheology and Microcirculation|April 10, 2018
DIBI, a polymeric hydroxypyridinone iron chelator, reduces ocular inflammation in local and systemic endotoxin-induced uveitisN Arora, A Caldwell, K Wafa, et al.
Neuropharmacology|August 20, 2018
Revisiting cannabinoid receptor 2 expression and function in murine retinaJoanna Borowska-Fielding, Natalia Murataeva, Ben Smith, et al.
Neuropharmacology|April 4, 2019
Positive allosteric modulation of the type 1 cannabinoid receptor reduces the signs and symptoms of Huntington's disease in the R6/2 mouse modelRobert B Laprairie, Amina M Bagher, Jillian L Rourke, et al.
ACS Chemical Neuroscience|January 20, 2017
Enantiospecific Allosteric Modulation of Cannabinoid 1 ReceptorRobert B Laprairie, Pushkar M Kulkarni, Jeffrey R Deschamps, et al.
ACS Chemical Neuroscience|April 6, 2016
Mapping Cannabinoid 1 Receptor Allosteric Site(s): Critical Molecular Determinant and Signaling Profile of GAT100, a Novel, Potent, and Irreversibly Binding ProbeRobert B Laprairie, Abhijit R Kulkarni, Pushkar M Kulkarni, et al.
Molecules (Basel, Switzerland)|September 22, 2019
Selective Cannabinoid 2 Receptor Agonists as Potential Therapeutic Drugs for the Treatment of Endotoxin-Induced UveitisRichard Frederick Porter, Anna-Maria Szczesniak, James Thomas Toguri, et al.
Toxicology Letters|January 26, 2021
Dose-dependent emergence of acute and recurrent corneal lesions in sulfur mustard-exposed rabbit eyesPatrick M McNutt, Kyle E M Kelly, Amber C Altvater, et al.
Journal of Medicinal Chemistry|April 7, 2021
Discovery of a Biased Allosteric Modulator for Cannabinoid 1 Receptor: Preclinical Anti-Glaucoma EfficacySumanta Garai, Luciana M Leo, Anna-Maria Szczesniak, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|October 6, 2022
Clinical, Virologic, and Immunologic Evaluation of Symptomatic Coronavirus Disease 2019 Rebound Following Nirmatrelvir/Ritonavir TreatmentBrian P Epling, Joseph M Rocco, Kristin L Boswell, et al.
Pageof 12